• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    Cingulate Unveils 2025 Financials And Operational Highlights

    GLOBENEWSWIRE

    Cingulate Appoints Bryan Downey Chief Commercial Officer

    GLOBENEWSWIRE

    Cingulate`s ADHD Drug Ctx-1301 Chosen For AACAP Annual Meeting

    GLOBENEWSWIRE

    Cingulate Partners with Bend Bio Sciences for ADHD Treatment

    GLOBENEWSWIRE

    Cingulate Submits ADHD drug CTx-1301 NDA to FDA

    GLOBENEWSWIRE

    Cingulate Gets $4.3M FDA Waiver for ADHD Asset CTx-1301 Approval

    GLOBENEWSWIRE

    Cingulate Reports Full Year 2024 Results and Milestones Update

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.